Skip to main navigation
Back
revance revance
  • Contact Revance
  • Login
Menu
  • Aesthetics
    Back Aesthetics
    Visit Site
    • Overview
    • RHA®
    • HintMD
    • Neuromodulator
    • Neuromodulator Uses
    • Clinical Highlights
  • Therapeutics
    Back Therapeutics
    • Overview
    • Cervical Dystonia
    • Upper Limb Spasticity
    • Plantar Fasciitis
    • Clinical Highlights
  • Investors
    Back Investors
    LATEST NEWS
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection All News
    • Investor Relations
    • Press Releases
    • Events & Webcasts
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Investor FAQ
  • Company
    Back Company
    OUR LATEST
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Our Latest
    • Overview
    • About Revance
    • Leadership Team
    • Board of Directors
    • Partnerships
    • Investigator Sponsored Trials
    • Medical Education Grants
    • Sustainability
    • Contact Revance
  • News
  • Careers
    Back Careers
    • Overview
    • Career Opportunities
    • Culture
    • Benefits & Perks
  • facebook
  • instagram
  • twitter
  • linkedin
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • Contact Revance
  • Login

© Copyright 2021

All Rights Reserved

Terms of Use

Privacy Policy

Breadcrumb

  • Home
  • Investors
  • Press releases

Press Releases

Press Releases

December 4, 2018
Revance Announces China Market License Agreement with Fosun Pharma for RT002
December 4, 2018
Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program
November 20, 2018
Revance to Participate in Upcoming Investor Conferences
November 7, 2018
Revance to Participate in the Credit Suisse Healthcare Conference
November 1, 2018
Revance Releases Third Quarter 2018 Results
October 18, 2018
Revance Therapeutics to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018
October 11, 2018
Revance Therapeutics Appoints Tobin C. Schilke as Chief Financial Officer
September 24, 2018
Revance to Participate in the Cantor Fitzgerald 2018 Global Healthcare Conference
September 20, 2018
Revance Receives Great Place to Work Certification
August 2, 2018
Revance Releases Second Quarter 2018 Results

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Next page next ›
  • Last page last »
Displaying 91 - 100 of 242

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Webcasts
    • Presentations and Corporate Materials
    • Video Library
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
image description

Revance - Shareholder Tools

  • Print Page
  • Printed Materials
  • Email Alerts
  • Download Library
  • RSS News Feeds
  • Share
  • Search

Keep up with Revance

revance
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • facebook
  • instagram
  • twitter
  • linkedin

Aesthetics

  • Overview
  • RHA®
  • HintMD
  • Neuromodulator
  • Neuromodulator Uses
  • Clinical Highlights

Therapeutics

  • Overview
  • Cervical Dystonia
  • Upper Limb Spasticity
  • Plantar Fasciitis
  • Clinical Highlights

Investors

  • Investor Relations
  • Press Releases
  • Events & Webcasts
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQ

Company

  • Overview
  • About Revance
  • Leadership Team
  • Board of Directors
  • Partnerships
  • Investigator Sponsored Trials
  • Medical Education Grants
  • Sustainability
  • Contact Revance

News

  • All News
  • In the News
  • Our Latest

Careers

  • Overview
  • Career Opportunities
  • Culture
  • Benefits & Perks
  • © Copyright 2021
  • All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • Corporate Social Media Community Guidelines
Back to top
  • Facebook
  • LinkedIn